Actuate Therapeutics Inc (ACTU) vs NextCure, Inc. (NXTC)
A side-by-side comparison of Actuate Therapeutics Inc and NextCure, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACTU
Actuate Therapeutics Inc
$0.81HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
NXTC
NextCure, Inc.
$5.69HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ACTU vs NXTC
growth of $100 · dividends reinvested · last 2yACTU -89.8% (-68.1%/yr)NXTC -73.7% (-48.7%/yr)NXTC compounded faster over this window
ACTU NXTC
ACTU vs NXTC: by the numbers
- •NXTC is the larger company ($21M vs $19M market cap).
Metrics side by side
Valuation
| Metric | ACTU | NXTC |
|---|---|---|
| P/B ratio | 19.63 | 1.69 |
Profitability
| Metric | ACTU | NXTC |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -2067.81% | -351.86% |
| ROIC | -1489.99% | -259.91% |
Growth (annualized)
| Metric | ACTU | NXTC |
|---|---|---|
| Total return CAGR (5Y) | N/A | -44.29% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.